Exhibiting at Fi South America 2025

Genu-in is a Brazilian manufacturer of collagen peptides and gelatin, launched as a strategic business unit of JBS Novos Negócios, the innovation and value-added segment of JBS S.A., one of the world’s largest protein companies. Officially established in 2021, Genu-in represents a major investment in health and nutrition ingredients, designed to address global demand for high-quality, traceable, and sustainable collagen-based solutions. ## Core Business Genu-in focuses on producing premium collagen peptides and gelatin for the nutraceutical, functional food, pharmaceutical, and pet nutrition sectors. Positioned as a B2B supplier, Genu-in leverages JBS’s robust supply chain to create ingredients that support human and animal well-being through scientifically grounded, clean-label formulations. ## Product and Service Offerings ### 1. Genu-in Life® – Collagen Peptides - High-purity peptides for functional nutrition - Formulated for: - Joint and bone health - Skin and beauty-from-within applications - Sports recovery and muscle support - Water-soluble and neutral in taste and odor - Halal and Kosher certified ### 2. Genu-in Gel® – Gelatin - Sourced from bovine hide - Applications: - Gummies and soft-chews - Dairy, desserts, and processed foods - Encapsulation and pharmaceutical gels - Offers excellent gelling strength, elasticity, and clarity ### Additional Services - Custom peptide formulation support - Technical assistance for applications across global markets - R&D collaboration with health & nutrition brands ## Specialization and USP - Vertical Integration: Full control from raw material sourcing (via JBS cattle processing) to final product ensures traceability and biosecurity. - Sustainability: Utilizes 100% by-products from meat processing, contributing to circular economy practices. - High-Performance Ingredients: Low-molecular-weight peptides with verified absorption and bioavailability. - Regulatory Readiness: Compliant with ANVISA, FDA, and global food safety standards. ## Financial Overview While Genu-in’s independent financials are not disclosed, the business operates under JBS S.A., which reported: - Net Revenue: USD 68.6 billion (2023, global) - Investment in Genu-in Facility: BRL 400 million (~USD 80 million) - Facility Launch: 2021 in Presidente Epitácio, São Paulo - Capacity: 4,000 tons/year of collagen peptides and gelatin - Employees: 350+ professionals directly involved in Genu-in operations ## Shipment and Trade Data As a B2B supplier, Genu-in exports bulk collagen peptides to over 25 countries within 3 years of launch. - HS Codes: 3503.00 (Gelatin and derivatives), 2106.90 (Nutraceutical collagen peptides) - Export Destinations: USA, Germany, China, Mexico, Japan - Strategic Partnerships: Distribution alliances with global firms such as Brenntag APAC and Barentz Latin America - Certifications: Halal, Kosher, FSSC 22000, HACCP, GMP ## Target Markets - Human Nutrition: - Nutraceuticals and dietary supplements - Functional food and beverage brands - Skin health and beauty-from-within products - Pharmaceutical and Medical Nutrition: - Oral drug delivery systems (capsules, gels) - Clinical nutrition for elderly and recovery patients - Pet Nutrition: - High-protein collagen-based formulations - Digestive and joint health for companion animals ## Capabilities - State-of-the-Art Facility: - Built with Industry 4.0 automation - Advanced hydrolysis reactors and filtration systems - Zero-waste water and energy reuse systems - Traceability System: - Full animal origin traceability (from JBS operations) - QR-code enabled product tracking - R&D and Technical Support: - Team of food technologists, chemists, and regulatory experts - Application labs in Brazil and through international partners ## Certifications and Compliance - FSSC 22000: Food Safety System Certification - HACCP & GMP: Standardized manufacturing protocols - Halal and Kosher Certifications - ANVISA Approved: Brazilian health and food safety authority - Global Market Access: Compliant with U.S. FDA, EFSA (Europe), and Codex Alimentarius ## Customer Testimonials and Industry Reputation Although direct testimonials are under NDA, public partnerships validate Genu-in’s growing credibility: - “We believe the Genu-in product line meets the evolving consumer demand for health, transparency, and sustainability. It complements our specialty portfolio for food and nutrition.” — Brenntag Asia Pacific Genu-in has been positively reviewed by clients in nutraceutical manufacturing for ingredient purity, supply chain transparency, and application versatility. ## Major Achievements - Launched Latin America’s largest collagen production plant in 2021. - Recognized as a global supplier within two years through international distribution partnerships. - Achieved regulatory clearance and market entry in 25+ countries within the first 30 months of operation. - Implemented full animal traceability system, rare in the global collagen market. - Named one of the top innovation launches by JBS in their 2022 global sustainability and innovation report. Genu-in is redefining the collagen ingredient space through advanced science, sustainable practices, and unmatched vertical integration, establishing itself as a future-forward solution provider for global health and nutrition markets.